Free STEP1 Exam Braindumps
Step1 Questions 291–295 (page: 60)

Updated On: 9-Feb-2026

Obesity, genetic profile, and aging all contribute to the development of Type II diabetes. Of the following, which is the most important additive factor for these three conditions in the development of Type II diabetes?

  1. elevated hepatic ketogenesis
  2. elevated pancreatic glucagon secretion
  3. impaired renal clearance of glucose
  4. increased adipose tissue activity leading to hyperlipidemia
  5. muscle resistance to insulin

Answer(s): E

Explanation:

The influence of obesity, genetic profile, and age on overall metabolism is most significant at the level of skeletal muscle sensitivity to the actions of insulin (below figure). Due to the overall mass of skeletal muscle in the body, the uptake of glucose by this tissue, and consequently its role in blood glucose homeostasis, is a significant factor in insulin responses. Progressive loss of skeletal muscle sensitivity to insulin leads to increased rates of visceral cell lipolysis and pancreatic beta-cell compensation. Eventually, the pancreas can no longer continue compensating for impaired insulin responses and pancreatic beta-cell decompensation occurs, further exacerbating the problem. The disrupted insulin response leads to increased hepatic gluconeogenesis, which further increases circulating glucose levels. The overall outcome of these reposnses is development of progressisely worsening Type II diabetes. Whereas, each of the other options (choices AD) will ensue due to impaired insulin responses in skeletal muscle, none is significant in the development of diabetes.



A2-month-old infant suffering from increased vomiting and diarrhea is seen in the hospital and observed to have significant abdominal distention due to hepatosplenomegaly. Unfortunately, the infant does not survive. Autopsy reveals calcification of the adrenals and massive accumulation of cholesteryl esters and triglycerides in most tissues. Analysis of enzyme activity in fibroblasts and lymphocytes demonstrates a significant acid lipase (cholesteryl ester hydrolase) deficiency. These clinical findings are indicative of which of the following disorders?

  1. hyperlipoproteinemia, type I (familial liproprotein lipase deficiency)
  2. I-cell disease (mucolipidosis type II)
  3. Maroteaux-Lamy syndrome
  4. Sanfilippo syndrome
  5. Wolman disease

Answer(s): E

Explanation:

Wolman disease results from a deficiency in the lysosomal acid lipase enzyme (also called cholesteryl ester hydrolase) and is very nearly always a fatal disease of infancy. Symptoms of the disorder arise from massive accumulation of cholesteryl esters and triglycerides in most tissues. Clinical manifestations include hepatosplenomegaly leading to abdominal distention, GI abnormalities, steatorrhea, and adrenal calcification. Type I hyperlipoproteinemia (choice A) results from a deficiency in LPL activity. LPL is the enzyme found on the surface of vessel endothelial cells and is responsible for hydrolyzing fatty acids from the triglycerides found in circulating liporpotein particles. This action allows cells to get fatty acids for energy production from lipoproteins in the plasma. This disoder leads to massive accumulation of chylomicrons and triglycerides in the plasma. Symptoms associated with type I hyperlipoproteinemia are usually detected in childhood and include eruptive cutaneous xanthomatosis, hepatosplenomegaly, and repeated episodes of abdominal pain. I-cell disease (choice B) results from a deficiency in the targeting of lysosomal enzymes to the lysosomes. Affected cells have dense inclusion bodies filled with storage material, hence the derivation of the disease name. There are elevated levels of lysosomal enzymes in the plasma and body fluids of I-cell patients. Symptoms include severe psychomotor retardation, coarse facial features, and severe skeletal abnormalities. The rapidly progressing disease can lead to death between 5 and 8 years of age. Maroteaux- Lamy syndrome (choice C) results from a defect in the enzyme N- acetylgalactosamine-4-sulfatase (arylsulfatase B) responsible for the catabolism of complex glycosaminoglycans. There are three distinct forms of Maroteax-Lamy syndrome that range in severity.
Symptoms include coarse facial features, skeletal abnormalities corneal clouding, and aortic valve disruption. Sanfillipo syndrome (choice D) comprises at least four distinct genetic defects that result from deficiencies in enzymes required for the catabolism of complex glycosaminoglycans of the heparan sulfate class. In all cases, the clinical symptoms are similar and include severe mental deterioration, hyperactivity, and disorders in the skin, lungs, heart, and skeletal muscle.



As a hypothetical approach to treating the hyperglycemia associated with Type II diabetes, a drug firm proposes to develop an inhibitor of liver glycogen phosphorylase. What is the biochemical rationale for this approach to inducing hypoglycemia?

  1. Hepatic fatty acid oxidation will decrease leading to reduced energy production needed for gluconeogenesis.
  2. Hepatocytes will have a reduced capacity to store glucose following meals.
  3. Liver glucose output will be reduced early during fasting.
  4. The resultant increase in glycogen storage will inhibit glucose uptake by the liver, leading to increased usage in skeletal muscle.
  5. There will be an increase in hepatic gluconeogenesis.

Answer(s): C

Explanation:

During early fasting, as the level of glucose in the blood falls, the pancreas releases glucagon into the circulation to counter this drop. The major site of glucagon action is the liver. There it induces the activity of the glycogen phosphorylase leading to an increase in glucose release from glycogen stores. Thus, an inhibition of glycogen phsphorylase would limit the ability of the liver to provide glucose to the blood.
Negatively affecting the activity of glycogen phosphorylase would not significantly affect the rate of hepatic fatty acid oxidation (choice A), skeletal muscle glucose usage (choice D), nor hepatic gluconeogenesis (choice E). The liver may have a reduced capacity for de novo storage of glucose following meals (choice B) due to a prior reduction in the release of glucose via the inhibition of glycogen phosphorylase; however, on fasting there would still be a reduction in glucose release.



Lipoprotein lipase (LPL) is the endothelial cellassociated enzyme necessary for release of fatty acids from circulating lipoproteins. Which of the following apolipoproteins is required to activate LPL- mediated release of fatty acids from chylomicrons?

  1. apo A
  2. apo
  3. apo
  4. apo CII
  5. apo E

Answer(s): D

Explanation:

The presence of apo CII on the surfaces of lipoprotein particles is necessary for the activation of endothelial cell LPL. Apo AI (choice A) activates LCAT. Apo (choice B) is derived via intestinal-specific RNA editing and is exclusively a component of chylomicrons. Apo (choice C) and E
(choice E) are necessary for LDL interaction with the LDL receptor.



Which of the following is the hypophyseotropic hormone that regulates the activity of the lactotrophs of the anterior pituitary?

  1. CRH
  2. GnRH
  3. growth hormone-releasing hormone (GRH)
  4. prolactin-releasing factor (PRF)
  5. thyrotropin-releasing hormone (TRH)

Answer(s): D

Explanation:

The lactotrophs of the anterior pituitary secrete prolactin in response to the action of PRF. Corticotropin- releasing hormone, CRH (choice A) regulates primarily the secretion of ACTH, but also other products of the ACTH precursor protein, pro-opiomelanocortin, POMC. GnRH (choice B) controls the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gonadotrophs. GRH (choice C) stimulates growth hormone secretion from pituitary somatotrophs. TRH (choice E) stimulates the thyrotropes to secrete thyroid-stimulating hormone, TSH (also called thyrotropin).



Viewing page 60 of 171
Viewing questions 296 - 300 out of 845 questions


Post your Comments and Discuss USMLE STEP1 exam prep with other Community members:

AI Tutor AI Tutor 👋 I’m here to help!